CIK 0000012208
- Large accelerated filer
BIO-RAD LABORATORIES, INC.
Sign in to watch- Tickers
- BIO BIO-B
- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 941381833
- Phone
- +1 510-724-7000
- Business address
- 1000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547
- Former names
- BIO RAD LABORATORIES INC
Securities
- BIO A Common Stock NYSE
- BIO-B B Common Stock NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,247,039
- in 3 filings
Net −$1,247,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-02 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +542 | 2,755.21 | ||
| 2023-09-02 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −269 | $394.60 | $106K | 2,486.21 |
| 2023-09-02 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −542 | 542 | ||
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +694 | 2,206.21 | ||
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −240 | $394.60 | $95K | 1,966.21 |
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +456 | 2,422.21 | ||
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −209 | $394.60 | $82K | 2,213.21 |
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +4,007 | 4,007 | ||
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −694 | 2,082 | ||
| 2023-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −456 | 912 | ||
| 2023-04-08 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +700 | 1,736.27 | ||
| 2023-04-08 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −243 | $466.24 | $113K | 1,493.27 |
| 2023-04-08 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −700 | 700 | ||
| 2022-09-02 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +541 | 1,222 | ||
| 2022-09-02 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −269 | $478.32 | $129K | 953 |
| 2022-09-02 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −541 | 1,084 | ||
| 2022-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion | +455 | 907 | ||
| 2022-09-01 | Daskal Ilan EVP, Chief Financial Officer | Shares withheld for taxes | −226 | $486.25 | $110K | 681 |
| 2022-09-01 | Daskal Ilan EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +2,776 | 2,776 | ||
| 2022-09-01 | Daskal Ilan EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −455 | 1,368 |
Page 1 of 3 · 48 trades